stars 1 stars 2 stars 3

Mercurna is a Netherlands-based biotech startup developing messenger RNA (mRNA) based medicines. To that end we are continuously perfecting our platform technology which combines unique cell-targeting ligands, with a proprietary lipid-based delivery vehicle to deliver engineered mRNA with high efficiency and high specificity to the diseased tissues. We leverage this platform in our pursuit of various life-changing medicines. We are in particular determined to deliver first-of-its-kind precision medicines for inflammatory diseases, with a current focus on (chronic) kidney disease.

Mercurna Questions

Jenny der Wijst is the CEO of Mercurna.

4 people are employed at Mercurna.

Mercurna is based in Nijmegen, Gelderland.

Top Mercurna Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users